Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111018807B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111018807B reveals a novel copper-catalyzed route for 1,2,4-thiadiazole derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN111018807B reveals a novel copper-catalyzed route for 1,2,4-thiadiazoles using elemental sulfur, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.